Abstract
All cases of mild acute pancreatitis (AP) and the majority of the severe forms of the disease are treated conservatively. Medical therapy is therefore of fundamental importance in the management of this disease. However, apart from the common devices of cardiovascular and respiratory support, thanks to which the early mortality in severe AP has been greatly reduced, to this day we do not have a specific and effective drug capable of acting on the physiopathology of the disease and of leading to a positive outcome. Antibiotic prophylaxis, equally a cornerstone of medical therapy, has for the past few years come under critical scrutiny.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Feldman M, Friedman LS, Sleisenger MH (2004) Malattie dell’apparato gastrointestinale e del fegato: pancreas-vie biliari. Excerpta Medica, Milano
Frossard JL, Steer ML, Pastor CM (2008) Acute pancreatitis. Lancet 371 (9618):143–152
Sabiston (2003) Trattato di chirurgia: le basi biologiche della moderna pratica chirurgica. (1st italian edn, 16th American edn). Antonio Delfino Editore, Roma
Chipman JG (2005) Acute pancreatitis in the surgical intensive care unit. In: Abrams JH, Druck P, Cerra FB (eds) Surgical critical care, 2nd edn. Taylor & Francis, London
Hayden P, Wyncoll D (2008) Severe acute pancreatitis. Curr Anaesth Crit Care 19:1
Whang EE (2006) Acute pancreatitis. In: Mulholland MW, Lillemoe KD, Doherty GM et al (eds) Greenfield’s surgery: Scientific principles and practice, 4th edn. Lippincott Williams & Wilkins, Philadelphia
Caronna R, Diana L, Nofroni I et al (2005) Effects of gabexate mesilate (FOY) on amylase and phospholipase A2 in human serum and pancreatic juice. Dig Dis Sci 50:868–873
Uhl W, Büchler MW, Malfertheiner P et al (1999) A randomized, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis. Gut 45:97–104
Heinrich S, Schäfer M, Rousson V, Clavien PA (2006) Evidence-based treatment of acute pancreatitis. A look at established paradigms. Ann Surg 243:154–168
Paran H, Mayo A, Paran D et al (2000) Octreotide treatment in patients with severe acute pancreatitis. Dig Dis Sci 45:2247–2251
Andriulli A, Leandro G, Clemente R et al (1998) Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12:237–245
Pederzoli P, Cavallini G, Falconi M, Bassi C (1993) Gabexate mesilate vs aprotinin in human acute pancreatitis (GA.ME.P.A.). A prospective, randomized, double blind, multicentre study. Int J Pancreatol 14:117–124
Chen HM, Chen JC, Hwang TL et al (2000) Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Hepatogastroenterology 47:1147–1150
Pezzilli R, Miglioli M (2001) Multicentre comparative study of two schedules of gabexate mesilate treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig Liver Dis 33:49–57
Messori A, Rampazzo R, Scroccaro G et al (1995) Effectiveness of gabexate mesilate in acute pancreatitis. A meta-analysis. Dig Dis Sci 40:734–738
Banfi R, Borselli G, Cappelletti S et al (2005) Gabexate mesilate and acute pancreatitis: an experience of evidence based drug information for improving rational drug use. Pharm World Sci 27:121–123
Nathens AB, Curtis JR, Beale RJ et al (2004) Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 32:2524–2535
Schein M (2005) Acute pancreatitis. In: Schein’s common sense emergency abdominal surgery. Springer, Berlin Heidelberg New York
Sanio V, Kemppainen E, Puolakkainen P et al (1995) Early antibiotic treatment in acute necrotizing pancreatitis. Lancet 346:663–667
Delcensire R, Yzet T, Ducroix JP et al (1996) Prophylactic antibiotics in treatment of severe acute alcoholic pancreatitis. Pancreas 13:198–201
Shwarz M, Isenmann R, Meyer H et al (1997) Antibiotic use in necrotizing pancreatitis: results of a controlled study. Dtsh Med Wochenschr 122:356–361
Pederzoli P, Bassi S, Vesentini S et al (1993) A randomized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obstet 176:480–483
Nordback I, Sand J, Saaristo R et al (2001) Early treatment with antibiotics reduces the need for surgery in acute necrotizing pancreatitis: a single-center randomized study. J Gastrointest Surg 5:113–119
Bassi C, Falconi M, Talamini G et al (1998) A controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Gastroenterology 115:1513–1517
Manes G, Rabitti PG, Menchise A et al (2003) Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas 27:79–83
Manes G, Uomo I, Menchise A et al (2006) Timing of antibiotic prophylaxis in acute pancreatitis: a controlled randomized study with meropenem. Am J Gastroenterol 101:1348–1353
Golub R, Siddiqi F, Pohl D (1998) Role of antibiotics in acute pancreatitis: a meta-analysis. J Gastrointest Surg 2:496–503
Bassi C, Larvin M, Villatoro E (2003) Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 4:CD002941
Sharma VK, Howden CW (2001) Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis. Pancreas 22:28–31
Zhou YM, Xue ZL, Li Ym et al (2005) Antibiotic prophylaxis in patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 4:23–27
Villatoro E, Bassi C, Larvin M (2006) Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 4:CD002941
Isenmann R, Runzi M, Kron M (2004) Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double blind trial. Gastroenterology 126:997–1004
Dellinger EP, Tellado JM, Soto NE et al (2007) Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double blind, placebocontrolled study. Ann Surg 245:674–683
Luiten EJT, Hop WCJ, Lange JF et al (1995) Controlled clinical trial of selective decontamination for the treatment of severe acute pancreatitis. Ann Surg 222:57–65
De Waele JJ, Vogelaers D, Blot S et al (2003) Fungal infections in patients with severe acute pancreatitis and the use of prophylactic therapy. Clin Infect Dis 37:208–213
Grewe M, Tsiotos GG, Luque de Leon E et al (1999) Fungal infection in acute necrotizing pancreatitis. J Am Coll Surg 188:408–414
He YM, Lu XS, Ai ZL et al (2003) Prevention and therapy of fungal infection in severe acute pancreatitis: a prospective clinical study. World J Gastroenterol 9:2619–2621
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Romiti, M., Minestroni, L., Siquini, W., Corradini, G. (2009). Medical Management of Acute Pancreatitis. In: Surgical Treatment of Pancreatic Diseases. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-0856-4_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-0856-4_6
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0855-7
Online ISBN: 978-88-470-0856-4
eBook Packages: MedicineMedicine (R0)